MedTrace Logo

Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma

NCT01960634 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2015-05-05

No results posted yet for this study

Summary

This is a multi-centric translational study with biological samples collection. The aim of this study is to validate a method to detect BRAFV600 in blood samples.

Samples: Blood from patients with BRAFV600 metastatic melanoma collected following standard medical practice.

The treatment is not the aim of the study. Patients can be treated either with specific or no-specific drug.

Conditions

  • Stage IV Skin Melanoma

Sponsors & Collaborators

  • Grupo Español Multidisciplinar de Melanoma

    lead OTHER

Principal Investigators

  • María González Cao, MD · Hospital Universitario Quirón Dexeus

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01960634 on ClinicalTrials.gov